Clinical Trial: CLINICAL STUDY TO DETERMINE BIOEQUIVALENCE BETWEEN TWO ORAL MEDICATIONS OF EMPAGLIFLOZIN/METFORMIN IN 12.5 mg / 500 mg TABLETS UNDER FED CONDITIONS.

U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07633054) titled 'CLINICAL STUDY TO DETERMINE BIOEQUIVALENCE BETWEEN TWO ORAL MEDICATIONS OF EMPAGLIFLOZIN/METFORMIN IN 12.5 mg / 500 mg TABLETS UNDER FED CONDITIONS.' on June 03.

Brief Summary: Prospective, longitudinal, single-dose, randomized, open-label, crossover 2x2, two treatments, two periods, two sequences controlled clinical study

Study Start Date: Sept. 10, 2025

Study Type: INTERVENTIONAL

Condition: Bioequivalence Study in Healthy Subjects

Intervention: DRUG: Synjardy 5/850 mg tablet, Reference

Synjardy 5/850 mg tablet, Reference

DRUG: Empagliflozin/metformin 12.5/500 mg test

Empagliflozin/metformin 12.5/500 mg test

Recruitment St...